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A  90-day  randomized,  double-blind,  placebo-controlled,  pre-post  trial was  conducted  in four  groups  of
Indonesian  children  aged  12–24  months:  placebo,  probiotic,  zinc,  and  a  combination  of probiotic  and  zinc
(n =  12  per  group).  Microencapsulated  Lactobacillus  plantarum  IS-10506  of  dadih origin  was  supplemented
at  a  dose  of 1010 CFU/day  as  a probiotic.  Zinc  was supplemented  as  20 mg  zinc  sulfate  monohydrate
(8 mg zinc  elemental).  Blood  and  stool  samples  were  collected  at  baseline  and at  the  end of  the  study
period.  Fecal  sIgA  was  assessed  by ELISA  and  serum  zinc  concentrations  by  ICP-MS.  Fecal  sIgA  increased
signiﬁcantly  in  the  probiotic  group  (30.33  ±  3.32 g/g; p  < 0.01)  and in  the  combination  probiotic  and  zinc
group  (27.55  ±  2.28  g/g;  p < 0.027),  as  compared  with  the  placebo  group  (13.58 ± 2.26 g/g).  Changes  in
serum  zinc  concentrations  in the combination  probiotic  and zinc  group  showed  the  highest  elevation  at
10the  end  of  the  study  period.  A  combination  of  probiotic  L.  plantarum  IS-10506  at a dose  of 10 CFU/day
and  8 mg  of  elemental  zinc  supplementation  showed  a potential  ability  to improve  the  zinc  status  of
pre-school  children.  Taken  together,  supplementation  with the probiotic  L. plantarum  IS-10506  and  zinc
for 90  days  resulted  in a  signiﬁcantly  increased  humoral  immune  response,  as  well  as  improved  zinc
status,  in  young  children.ntroduction
Dietary supplementation is an attractive, non-invasive means
f enhancing and optimizing important physiological functions,
ncluding the immune system [1]. The ability of dietary supple-
entation to optimize immune function is seen as particularly
mportant among those groups of individuals who may  have an
nder-developed or poorly functioning immune system, such as
nfants, young children, immunocompromised subjects and the
lderly [2,3].
Recent advances in research have greatly increased understand-
ng of the importance of the gut microbiota. Bacterial colonization
f the intestine in a gut-microbiome system is critical to the normal
evelopment of many aspects of physiology. Further understanding
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of the mechanisms underlying the gut-microbiome will provide
new insight into the symbiotic relationship between gut microbiota
and their mammalian hosts, and help to identify the potential for
microbial-based preventive strategies to aid in health promotion.
Probiotics are deﬁned as living microorganisms that when
administered in adequate amounts, confer a health beneﬁt to
human health [4]. Lactobacillus plantarum IS-10506 is a novel
probiotic strain isolated from a yogurt-like product, dadih,  an
Indonesian traditional buffalo milk of West Sumatera origin [5].
In vitro probiotic properties have been proven, such as acid and
bile tolerance, adhesion properties, and competitiveness against
pathogens [6,7]; in vivo [8,9] and human studies have been con-
ducted in serial studies [10–12].
The primary functions of the gastrointestinal tract are digestion
and absorption of nutrients, and electrolyte and water homeostasis;
hence, the integrity of the intestinal brush border is a key element
in preventing systemic absorption of enteric toxins and bacteria.
Gastrointestinal lymphoid tissue plays an important role in con-
trolling transepithelial passage of bacteria across the intestinal
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ucosa by synthesizing more antibody molecules than any other
ymphoid tissue. Gastrointestinal antibodies are produced in the
orm of immunoglobulin and are key players in efﬁcient humoral
ucosal immunity, in particular the maintenance of the integrity
f the epithelial barrier.
Zinc is an essential trace element of exceptional biologic and
ublic health importance. Zinc is an essential component of a large
umber of enzymes, and plays a central role in cellular growth
nd differentiation of tissues with rapid turnover, including the
mmune system and the gastrointestinal tract [13,14]. Zinc deﬁ-
iency involves impaired immune function, sub normal growth and
evelopment, and in children causes growth retardation, delayed
exual maturation, and infection susceptibility. Intervention trials
ave demonstrated that the supplementation with zinc can also
nhance the immune response [15]. There is no evidence that zinc
auses harm when given to non-septic, immunocompetent chil-
ren [16].
aterials and methods
reparation of diets
The tested powder contained maltodextrin as placebo and pro-
iotic L. plantarum IS-10506 of dadih origin was identiﬁed by 16S
RNA gene sequencing as L. plantarum (Gene Bank accession no.
Q860148). For experimental purposes, microencapsulated bacte-
ia were incorporated at a dose of 2.3 × 1011 CFUs/g powder, and
as been shown to exhibit neither signiﬁcant loss of viability nor
ontamination because of storage during the entire study period.
inc was supplemented as zinc sulfate powder. Placebo, probiotic
r zinc were given in microencapsulated form and were identical
n appearance.
ubjects and trial criteria
Forty-eight apparently healthy children within the age range of
2–24 months (median 16.8 months) were selected for this study.
rior to commencement of the trial, the selection criteria were
enerated from the records of participating health care providers.
nclusion criteria were apparently healthy children, between the
ges of 12 and 24 months and agreement to conform to the trial
uidelines or provide notiﬁcation of non-compliance. Exclusion
riteria were congenital abnormality or disease, gastrointestinal
isease, regular use of products with probiotic bacteria, receiving
ntibiotic therapy within two weeks prior to the intervention study
nd non-agreement to avoid potentially conﬂicting nutritional or
race element supplements during the 90 days of the trial. Com-
liance with supplementation was conﬁrmed by the subjects by
irect report to the health care provider.
rotocol
The trial protocol was approved by the Faculty of Medicine, Uni-
ersity of Indonesia Ethics Committee. Participation in the study
as voluntary, and written informed consent was obtained before
he start of the study from the parents or guardian of children
or their child’s participation in the study. The study period was
rom August 2009 to March 2010 in Larangan, Ciledug districts,
angerang, Banten Province, Indonesia. The study was  a double-
lind, randomized, placebo-controlled pre-post intervention trial.
aterial Transfer Agreement was obtained from Ministry of Health
or analyses of blood samples in Japan.
Subjects were randomly assigned consecutively into four
roups: placebo, probiotic, zinc, and combination of probiotic
nd zinc. At enrollment, children were randomized using sealed
nvelopes containing a note assigning the subject to one of theedicine and Biology 28 (2014) 465–469
four study arms. There were 36 children (19 boys) in the study
groups (supplemented), and 12 (7 boys) in the control group.
The probiotic L. plantarum IS-10506 was  supplemented at a dose
of 2.3 × 1010 CFUs per day; zinc was  supplemented at a dose of
20 mg/day as zinc sulfate. Supplementation was conducted for 90
days. Age, sex, weight, adverse events were recorded for each child,
and a physical examination was conducted by a physician every
one month during the intervention study. Two  children in the zinc
group and one child in the combination probiotic and zinc group
were dropped from the study because they moved out of town and
the blood sample was not sufﬁcient.
Stool and blood sample collection
Peripheral blood samples were withdrawn from subjects by
venipuncture and stool samples were collected at baseline and at
the end of the study period. Fecal secretory IgA (sIgA) was assessed
by ELISA kit at the Institute of Human Virology and Cancer Biology
(IHVCB) laboratory, Faculty of Medicine, University of Indonesia,
and serum zinc was  assessed by ICP-MS in the Trace Element Lab-
oratory, Department of Public Health, Gunma University Graduate
School of Medicine, Japan.
Analysis of fecal sIgA
Fresh samples of stool were collected in the morning and
transported immediately to the laboratory and stored at −80 ◦C.
Measurements of sIgA were carried out using ELISA kits (K8870
and K6500, Immundiagnostik, Bensheim, Germany) according to
the manufacturer’s instructions.
Stool samples weighing 80–120 mg  were diluted with appro-
priate amounts of buffer provided in the kit to give constant
dilutions. The stool were suspended in diluent buffer, vortexed,
and centrifuged at 13,000 rpm (=13,000 × g) for 5 min  in 1.5 mL
tubes. Supernatants were diluted 1:250 in wash buffer. Standards,
controls and stool samples were simultaneously transferred to
microplates coated with antibodies speciﬁc for sIgA. Anti-sIgA
antibody conjugated with peroxidase was used for development.
For each well, the optical density was measured at 450 nm on a
microplate ELISA reader (Dynex, Heidleberg, Germany). The results
of the test samples were calculated from the standard curve and
expressed as concentration (g/g) by wet  weight of stool.
Serum blood preparation and zinc analysis
Venous blood samples were collected from children and cen-
trifuged at 3000 rpm for 10 min  to obtain serum and kept at −80 ◦C
until analysis. Each serum sample (0.1 mL)  was  digested with 1 mL
of 60% ultrapure nitric acid and 0.1 mL of 30% ultrapure hydrogen
peroxide in a perﬂuoroalkoxy polymer vessel using the following
procedure: heating at 90 ◦C for 0.5 h, heating at 120 ◦C for 2.5 h, and
ﬁnally heating at 150 ◦C for 2 h on a hot plate. After cooling, the
digested solutions of serum were diluted up to 5 mL  with Milli-Q
water in polypropylene sample tubes. Blank and certiﬁed reference
materials (CRMs) were subjected to the same treatment as the sam-
ples. To minimize contamination from devices, all containers were
soaked in an acid bath (a solution of 6% (V/V) of nitric acid) for a
minimum of 24 h, followed by ﬁnal rinses with Milli-Q water.
Serum zinc concentrations were analyzed by inductively cou-
pled plasma mass spectrometry (ICP-MS) with an ELAN DRC II
(Perkin Elmer, Waltham, MA,  USA). The accuracy of the analysis
was checked with CRMs: Seronorm Trace Element Serum Level 2
(No.203105, Billingstad, Norway). Results were in agreement with
the reference values.
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Table  1
Post hoc statistical analysis of changes in fecal sIgA levels after 90 days of supplementation.
(I) Treatment/placebo (J) Treatment/placebo Mean difference (I − J) Std. error P value 95% Conﬁdence interval
Lower bound Upper bound
Placebo
Probiotic −0.08044a 0.02262 0.001a −0.1261 −0.0348
Zinc  −0.04452 0.02373 0.068 −0.0924 0.0034
Probiotic Zinc −0.05293a 0.02313 0.027a −0.0996 −0.0062
Probiotic
Placebo 0.08044a 0.02262 0.001 0.0348 0.1261
Zinc  0.03592 0.02373 0.138 −0.0120 0.0838
Probiotic Zinc 0.02751 0.02313 0.241 −0.0192 0.0742
Zinc
Placebo 0.04452 0.02373 0.068 −0.0034 0.0924
Probiotic −0.03592 0.02373 0.138 −0.0838 0.0120
Probiotic Zinc −0.00841 0.02421 0.730 −0.0573 0.0405
Probiotic Zinc
Placebo 0.05293a 0.02313 0.027 0.0062 0.0996
Probiotic −0.02751 0.02313 0.241 −0.0742 0.0192
Zinc  0.00841 0.02421 0.730 −0.0405 0.0573
a
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aThe mean difference is signiﬁcant at the 0.05 level.
tatistical analysis
Differences between before and after supplementation were
nalyzed using paired t-tests. Differences between groups were
nalyzed by one-way ANOVA, Mann–Whitney U, Kruskal–Wallis
nd Chi-square tests, as appropriate. Data were checked for normal-
ty by visual inspection of the normal probability curves and with
he Shapiro–Wilk test of normality. In the statistical analysis, chil-
ren in probiotic, zinc and probiotic-zinc groups were compared
ith children that received placebo for changes in fecal sIgA and
erum zinc after 90 days of supplementation. P-values of less than
.05 were considered signiﬁcant.
esults
Forty-eight children of median age 17 months (range 12–24
onths) were recruited for the study. The median socioeconomic
tatus was categorized as lower middle class. No signiﬁcant change
n bowel frequency (median daily frequency = 1) or stool consis-
ency was reported during consumption of the probiotic. There
as no signiﬁcant complaint of abdominal pain or bloating or other
bdominal symptoms during supplementation.
Fig. 1. Changes in fecal sIgA (g/g) levels in the placebo, probiotic, zinc and combinationChanges in fecal sIgA levels of the placebo, probiotic, zinc
and combination of probiotic and zinc groups in the subjects
after 90 days were 13.58 ± 2.26, 30.33 ± 3.32, 20.5 ± 1.73, and
27.55 ± 2.28 g/g feces, respectively. The changes in fecal sIgA
levels in the subjects after 90 days of probiotic L. plantarum
IS-10506 supplementation (p = 0.001) and the combination of pro-
biotic L. plantarum IS-10506 and zinc supplementation (p = 0.027)
were signiﬁcantly higher than in the placebo group (Table 1,
Fig. 1).
Serum zinc concentrations in children of the placebo, pro-
biotic, zinc and combination of probiotic and zinc groups
before supplementation were 699.94 ± 164.81, 764.02 ± 157.90,
704.27 ± 152.07, and 662.16 ± 183.13 ng/mL, respectively. Serum
zinc concentrations in children after 90 days supplemen-
tation were 668.62 ± 94.87, 744.52 ± 128.80, 748.81 ± 170.38, and
739.79 ± 163.14 ng/mL, respectively (Fig. 2). Serum zinc concentra-
tions in children supplemented with the combination of probiotic L.
plantarum IS-10506 and zinc after 90 days was signiﬁcantly higher
than before supplementation (p < 0.05). Furthermore, changes in
serum zinc concentrations of children supplemented with the
combination of probiotic L. plantarum IS-10506 and zinc were sig-
niﬁcantly higher than the placebo group (p < 0.05).
 probiotic and zinc groups after 90 days of supplementation.*p < 0.05, **p < 0.001.
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iscussion and conclusion
Studies in healthy children and preterm infants have shown
n increase in fecal IgA excretion in response to probiotic inter-
entions [17,18]. A study in animals showed that probiotic yogurt
ontaining Lactobacillus casei increased IgA secretion in mice [19].
n another study, salivary sIgA in Indonesian children younger than
ve was increased signiﬁcantly in response to the probiotic Entero-
occus faecium IS-27526 of dadih origin, supplemented at a dose of
08 CFU/day for 90 days [20].
Ingested probiotic bacteria interact with gut epithelial cells in
 strain-dependent manner. The effects of L. plantarum IS-10506,
s well as E. faecium IS-27526, on the humoral immune response
ould be the result of colonization and adhesion to epithelial cells,
n efﬁcient inducer of sIgA production, by the cell wall component
f probiotics, such as lipoteichoic acids and peptidoglycan [7].
Both strong immune responses and gut integrity play impor-
ant roles in the repair of intestinal brush border damage as a
esult of the balance of microbiota. Probiotic microorganisms pos-
tively change the intestinal microbiota, inhibit the growth of
athogenic bacteria, promote adequate digestion, stimulate local
mmune function, and increase resistance to infection.
The immunological properties of probiotic bacteria have been
tudied previously [21] and have shown that certain lactic acid
acteria, such as L. casei, Lactobacillus rhamnosus, and L. plantarum,
nhance both systemic and mucosal immunity. Food containing
robiotic bacteria are able to stimulate the IgA immune response
22].
In addition to probiotics, intervention trials have demonstrated
hat supplementation with zinc can also enhance the immune
esponse [23]. The rationale for the beneﬁcial effects of zinc
upplementation is based on the depletion of zinc because of mal-
ourishment and the deleterious effects of zinc deﬁciency on the
mmune system, leading to more severe enteric infections. There is
lso no evidence that zinc causes harm when given to non-septic,
mmune competent children [16].
Because zinc and probiotics work via different mechanisms, it is
ossible that adding both would have a synergistic effect, as shown
y the signiﬁcant increase in fecal sIgA (p = 0.027) in the children
upplemented with the combination of probiotic L. plantarum IS-
0506 and zinc after 90 days (Fig. 1).
Children are at risk for zinc deﬁciency. Infants and young chil-
ren are the most vulnerable as shown by the decline of serumnd after 90 days of supplementation in each group.
zinc levels of those children in the placebo and probiotic groups
(Fig. 2), which may  lead to zinc deﬁciency. The lack of reliable,
widely accepted, and adequate sensitive indicators of zinc status
has resulted in uncertainty about the global prevalence of zinc
deﬁciency. ICP-MS is an accurate and sensitive instrument for
measuring zinc levels in the blood plasma and can detect zinc at
concentrations in the ng/mL range.
Supplementation with zinc and its combination with the probio-
tic L. plantarum IS-10506 showed signiﬁcant increases in zinc levels
after 90 days in young children. This might be the result of a syn-
ergic effect between the probiotic and zinc, or might be because of
the integrity of the intestine, which in turn will be able to optimize
the absorption of zinc.
Zinc is necessary for the activity of some immunity media-
tors. The human body contains 2–4 g of zinc, but in the plasma or
serum blood zinc only occurs in a concentration of 12–16 mol/L.
Although very small, it is highly mobile and immunologically
important [24]. Zinc is necessary for normal function of the
immune system [25] as shown by thymulin, anonapeptidic
hormone (Glu–Ala–Lys–Ser–Gln–Gly–Gly–Ser–Asn) secreted by
thymic epithelial cells, that requires the presence of zinc for its
biological activity [26].
Fermented dairy products with added probiotics are interesting
targets for zinc fortiﬁcation. Probiotics are well known for their
positive impact on intestinal health and stimulation of immune
response [27]. Because both zinc and probiotics have beneﬁcial
effects on nutritional and immunological status, the effect when
taken together could be ampliﬁed, resulting in improved mineral
absorption or a higher cellular immune response.
Supplementation with the probiotic L. plantarum IS-10506
signiﬁcantly increased fecal sIgA after 90 days at a dose of
1010 CFU/day (p = 0.01). A combination of the probiotic L. plan-
tarum IS-10506 at a dose of 1010 CFU/day and 8 mg  of elemental
zinc supplementation showed the potential ability to improve zinc
status of pre-school children as shown by the highest elevation
of serum zinc (p = 0.05), as well as high changes in fecal sIgA
(p = 0.027). No adverse events were observed in the children.
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